In conclusion, our findings illuminate a novel HIF1α/miR-5100/QKI pathway in HNSCC metastasis, and suggest that miR-5100 might be a potential biomarker and therapeutic target for HNSCC. The gene discussed is HIF1A; the disease is head and neck squamous cell carcinoma.